View in EDS HTML Full Text PDF Full Text

Pediatric Endocrine Society Statement on Considerations for Use of Teplizumab (Tzield™) in Clinical Practice.

Saved in:
Bibliographic Details
Title: Pediatric Endocrine Society Statement on Considerations for Use of Teplizumab (Tzield™) in Clinical Practice.
Authors: Mehta, Shilpa1 (AUTHOR), Ryabets-Lienhard, Anna2 (AUTHOR), Patel, Neha3 (AUTHOR), Breidbart, Emily4 (AUTHOR), Libman, Ingrid5 (AUTHOR), Haller, Michael J.6 (AUTHOR), Simmons, Kimber M.7 (AUTHOR), Sims, Emily K.8 (AUTHOR), DiMeglio, Linda A.8 (AUTHOR), Gitelman, Stephen E.9 (AUTHOR), Griffin, Kurt J.10 (AUTHOR), Tonyushkina, Ksenia N.11 (AUTHOR)
Source: Hormone Research in Paediatrics. 2025, Vol. 98 Issue 5, p597-608.
Database: SPORTDiscus with Full Text
Full text is not displayed to guests.
Description
ISSN:16632818
DOI:10.1159/000538775